Organogenesis Holdings Inc.

ORGO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Aug 6, 2026 8-K
424B5 Aug 6, 2026 424B5
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
8-K Jun 16, 2026 8-K
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
ARS Apr 30, 2026 ARS
DEF 14A Apr 30, 2026 DEF 14A
4 Apr 24, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Mar 11, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Mar 11, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Mar 3, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4/A Mar 3, 2026 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4/A Mar 3, 2026 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4/A Mar 3, 2026 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4/A Mar 3, 2026 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4/A Mar 3, 2026 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4/A Mar 3, 2026 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4/A Mar 3, 2026 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
3 Feb 27, 2026 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
10-K Feb 26, 2026 10-K
8-K Feb 26, 2026 8-K
8-K Feb 23, 2026 8-K
4 Feb 20, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
← Newer Page 1 of 27 · 671 filings Older →